Literature DB >> 24574707

Molecular basis of the irritable bowel syndrome.

Anna Vaiopoulou1, Georgios Karamanolis1, Theodora Psaltopoulou1, George Karatzias1, Maria Gazouli1.   

Abstract

Irritable bowel syndrome (IBS) is a functional disorder characterized by abdominal pain, discomfort and bloating. The pathophysiology of IBS is poorly understood, but the presence of psychosocial basis is now known. There is an increasing number of publications supporting the role of genetics in IBS. Most of the variations are found in genes associated with the brain-gut axis, revealing the strong correlation of brain-gut axis and IBS. miRNAs, which play critical roles in physiological processes, are not well studied in IBS. However, so far there is found an involvement of alterations in miRNA expression or sequence, in IBS symptoms. IBS phenotype is affected by epigenetic alteration and environment. Changes in DNA and histone methylation are observed in patients who suffered childhood trauma or abuse, resulting in altered gene expression, such as the glucocorticoid receptor gene. Finally, diet is another factor associated with IBS, which may contribute to symptom onset. Certain foods may affect on bacterial metabolism and epigenetic modifications, predisposing to IBS.

Entities:  

Keywords:  Diet; Epigenetics; Gastrointestinal diseases; Genetics; Irritable bowel syndrome

Mesh:

Substances:

Year:  2014        PMID: 24574707      PMCID: PMC3923013          DOI: 10.3748/wjg.v20.i2.376

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  82 in total

Review 1.  Epigenetics and the nervous system.

Authors:  Mark F Mehler
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

2.  Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.

Authors:  Alexandra-Chloé Villani; Mathieu Lemire; Marroon Thabane; Alexandre Belisle; Geneviève Geneau; Amit X Garg; William F Clark; Paul Moayyedi; Stephen M Collins; Denis Franchimont; John K Marshall
Journal:  Gastroenterology       Date:  2010-01-04       Impact factor: 22.682

3.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene.

Authors:  S E Löfgren; J Frostegård; L Truedsson; B A Pons-Estel; S D'Alfonso; T Witte; B R Lauwerys; E Endreffy; L Kovács; C Vasconcelos; B Martins da Silva; S V Kozyrev; M E Alarcón-Riquelme
Journal:  Genes Immun       Date:  2012-01-05       Impact factor: 2.676

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

Review 6.  Scope of the problem of functional digestive disorders.

Authors:  N J Talley
Journal:  Eur J Surg Suppl       Date:  1998

Review 7.  Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.

Authors:  Shin Fukudo
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

8.  The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.

Authors:  Pontus Karling; Åke Danielsson; Mikael Wikgren; Ingegerd Söderström; Jurgen Del-Favero; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

9.  First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.

Authors:  Johannes Kapeller; Lesley A Houghton; Hubert Mönnikes; Jutta Walstab; Dorothee Möller; Heinz Bönisch; Barbara Burwinkel; Frank Autschbach; Benjamin Funke; Felix Lasitschka; Nikolaus Gassler; Christine Fischer; Peter J Whorwell; Wendy Atkinson; Catherine Fell; Karl J Büchner; Marco Schmidtmann; Ivo van der Voort; Anna-Sophia Wisser; Thomas Berg; Gudrun Rappold; Beate Niesler
Journal:  Hum Mol Genet       Date:  2008-07-09       Impact factor: 6.150

10.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

View more
  8 in total

1.  The CCL28 levels are elevated in the serum of patients with irritable bowel syndrome and associated with the clinical symptoms.

Authors:  Farshad Sheikhesmaili; Ali Jalili; Elmira Taghizadeh; Shohreh Fakhari; Khashaiar Jalili; Ebrahim Ghaderi; Ezatollah Rahimi
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

2.  Neuroimaging the brain-gut axis in patients with irritable bowel syndrome.

Authors:  Kristen R Weaver; LeeAnne B Sherwin; Brian Walitt; Gail D'Eramo Melkus; Wendy A Henderson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

3.  Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.

Authors:  Xiwen Ling; Siyuan Peng; Jingbin Zhong; Lirong Guo; Yaqin Xu; Xiaobao Jin; Fujiang Chu
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

Review 4.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

Review 5.  Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.

Authors:  Luis Alberto Bravo-Vázquez; Ixchel Medina-Ríos; Luis David Márquez-Gallardo; Josué Reyes-Muñoz; Francisco I Serrano-Cano; Surajit Pathak; Antara Banerjee; Anindya Bandyopadhyay; Asim K Duttaroy; Sujay Paul
Journal:  Dig Dis Sci       Date:  2022-05-04       Impact factor: 3.487

Review 6.  The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations.

Authors:  Mihaela Fadgyas-Stanculete; Ana-Maria Buga; Aurel Popa-Wagner; Dan L Dumitrascu
Journal:  J Mol Psychiatry       Date:  2014-06-27

Review 7.  Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines.

Authors:  Sunil Kumar; Awanish Kumar; Priyanka Singh
Journal:  Clin J Gastroenterol       Date:  2021-12-04

Review 8.  Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise-Searching for Gap Fillers in the Oxidative Stress Way of Thinking.

Authors:  Ioana-Miruna Balmus; Ovidiu Ilie-Dumitru; Alin Ciobica; Roxana-Oana Cojocariu; Carol Stanciu; Anca Trifan; Mirela Cimpeanu; Cristian Cimpeanu; Lucian Gorgan
Journal:  Medicina (Kaunas)       Date:  2020-01-19       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.